Eltropag 50mg Tablet: Effective Medication for Your Health

Eltropag 50mg Tablet

Uses:

• Treatment of low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
• Treatment of severe aplastic anaemia.

Mechanism of action:

• Eltropag 50mg Tablet stimulates megakaryocytes, the large bone marrow cells responsible for producing platelets.
• By raising the number of platelets in the blood, this drug prevents bleeding and bruising.

Important safety information:

• Hypersensitivity: Do not use if you have known hypersensitivity or allergic reactions to the drug or its components.
• Liver impairment: Contraindicated in patients with severe liver impairment or active liver disease.
• Pregnancy and breastfeeding: Not recommended for pregnant patients or those breastfeeding.
• Driving: Driving vehicles or operating heavy machinery is unsafe after taking the Eltropag 50mg Tablet. It may cause dizziness and impair concentration.
• Interaction with other drugs: Inform your healthcare provider about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.

How to consume:

• It is an orally available prescription drug.
• Your doctor will decide the dose and duration of the drug based on the disease condition and other factors.
• Always take an Eltropag 50mg Tablet as prescribed by your doctor.
• Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.

Side effects:

• Common side effects include nausea, diarrhea, abdominal pain, common cold, cough, respiratory tract infection, back pain, high temperature, loss of appetite, hair loss, swelling in feet or hands, headache, dizziness, mouth and throat pain, joint pain.

Storage:

• Store Eltropag 50mg Tablet at room temperature (25°C).
• Keep the medicine out of reach of children and pets.

FAQ:

1. What is ITP? Immune thrombocytopenia, also known as ITP, is a rare blood disorder. People with ITP have insufficient platelets in their blood. A low platelet count can cause bruising and bleeding.
2. Who should not use the Eltropag 50mg Tablet? People with immune (primary thrombocytopenia (ITP) and children under one should not use Eltropag 50mg Tablet. It is also not suggested for people with severe aplastic anemia and hepatitis C.
3. Will you be monitored during treatment with the Eltropag 50mg Tablet? Yes, you will be monitored during the Eltropag 50mg Tablet. Your healthcare provider will regularly access your white blood cell, platelets, blood clotting factors, heart rate, eye test, and complete blood count.
4. Is it safe to take Eltropag 50mg Tablet on an empty stomach? Yes, Eltropag 50mg Tablet should be taken on an empty stomach. Because antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminum, selenium, and zinc), dairy products, calcium-enriched foods, and fortified juices interfere with this drug absorption. So, please take them at least two hours before or four hours after taking the medication.
5. What happens if you discontinue using the Eltropag 50mg Tablet? If you discontinue using Eltropag 50mg Tablet suddenly, it decreases platelet count as it can lead to severe bleeding. However, telling your healthcare practitioner before discontinuing this medication is advisable.
6. How to store Eltropag 50mg Tablet? Store Eltropag 50mg Tablet at 25°C and out of the reach of children. After the expiration date, do not use this medication.

Fact box:

• Molecule name: Eltrombopag
• Therapeutic class: Anticoagulant
• Pharmacological class: Thrombopoietin (TPO) receptor agonist
• Indications:
  • Low platelet counts caused by immune primary thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
  • Severe aplastic anaemia.

Tags: Eltropag, tablets, medication, 50mg, health, drug, pharmacy, prescription, cardiovascular